MARKETS
Markets

EXCLUSIVE: FibroBiologics Files US Patent Application For New Technology Designed To Produce GLP-1 And Other Therapeutic Peptides Inside The Body, As An Alternative To Repeated Injections

Oct 7, 2026 · 08:15 AM ET· updated 1h ago

Share
Why It Matters

FibroBiologics filed a patent for technology that makes medicine inside your body. Instead of getting shots over and over, your body could make the medicine itself.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.